Company intelligence / Profile preview
Staidson Biopharmaceutical
Beijing, Beijing, China
- Ownership
- Public · 300204
- Employees
- ~600
- Development stage
- Other
01
Overview
Staidson Biopharmaceutical is a leading Chinese biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutic products. The company is best known for its flagship product, Shutaifen (Mouse Nerve Growth Factor), which is widely used in China for nerve injury repair and neurological recovery. Staidson's robust R&D pipeline targets high-potential areas such as complement-mediated inflammatory diseases, infectious diseases, and gene therapy. Key clinical candidates include BDB-001, a monoclonal antibody targeting C5a, and STSG-0002, an RNAi-based treatment for Hepatitis B. The company operates integrated manufacturing facilities and maintains strategic global partnerships, notably with InflaRx, to advance its clinical programs.
- Therapeutic areas
- HematologyImmunologyNeurologyDermatologyInfectious DiseasesGastroenterology
- Modalities
- Monoclonal antibodyRecombinant proteinSmall moleculeRNA therapyGene therapy
- Industry
- Biotech
02
Drug pipeline
34 assets33 more assets in the full pipeline.
Request access →03
Partnerships
InflaRx
Beyond the preview
Go deeper on Staidson Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Staidson Biopharmaceutical.